Article
Dasatinib‑Associated Chylothorax and Concurrent Bartonella henselae Infection in leukaemia Patients: A Systematic Review of Case Reports
2026-05-16
Abstract excerpt
Dasatinib is a second‑generation tyrosine kinase inhibitor (TKI) used in Philadelphia chromosome‑positive (Ph+) acute lymphoblastic leukaemia (ALL), and chylothorax is one of its rare but serious lymphatic complications. At the same time, patients with leukaemia are particularly vulnerable to atypical Bartonella henselae infection. This systematic review of multiple databases up to March 2026 identified 25 cases o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6e8f3ccf-69e4-5a9b-8629-9093dfa7c679
- DOI
- 10.22541/authorea.15003412/v1
